Michael Franti
10Patents
2h-index
21Co-inventors
50Inventor score
Filing activity: Jun 13, 2003 → Jun 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7939083B2 | Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain | Chemistry; Metallurgy | 40 | Active |
| US11078237B2 | Antigen delivery platforms | Chemistry; Metallurgy | 37 | Active |
| US8945904B2 | Influenza virus reassortment | Chemistry; Metallurgy | 1 | Active |
| US9072702B2 | Reverse genetics using non-endogenous pol I promoters | Chemistry; Metallurgy | 1 | Active |
| US8883481B2 | Reverse genetics methods for virus rescue | Chemistry; Metallurgy | 0 | Active |
| US9821052B2 | Reverse genetics systems | Chemistry; Metallurgy | 0 | Active |
| US6926899B2 | Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test | Physics | 0 | Expired |
| US10610584B2 | Reverse genetics systems | Chemistry; Metallurgy | 0 | Active |
| US11639370B2 | Antigen delivery platforms | Chemistry; Metallurgy | 0 | Active |
| US9574181B2 | Influenza virus reassortment method | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.